Web Results

caselaw.findlaw.com/us-supreme-court/09-152.html

United States Supreme Court. BRUESEWITZ ET AL. v. WYETH LLC, FKA WYETH, INC., ET AL., (2011). No. 09-152. Argued: October 12, 2010 Decided: February 22, 2011. The National Childhood Vaccine Injury Act of 1986 (NCVIA or Act) created a no-fault compensation program to stabilize a vaccine market adversely ...

law.justia.com/cases/federal/district-courts/FSupp2/92/954/2529602

Nelson v. American Home Products Corp., 92 F. Supp. 2d 954 (W.D. Mo. 2000) case opinion from the U.S. District Court for the Western District of Missouri. ... Damien C. Macaluso, M.D. et al., Features of Amiodarone-Induced Optic Neuropathy, 127 AMERICAN JOURNAL OF OPHTHALMOLOGY 610 (May 1999) .

www.cafc.uscourts.gov/sites/default/files/opinions-orders/15-1871.Opinion.8-11-2016.1.PDF

Aug 16, 2016 ... Before LOURIE, WALLACH, and HUGHES, Circuit Judges. LOURIE, Circuit Judge. Apotex Inc. appeals from the U.S. Patent and Trade- mark Office Patent Trial and Appeal Board (“the Board”) final written decision in an inter partes review concluding that claims 1–23 of U.S. Patent 7,879,828 (“the '828.

healthland.time.com/2011/02/24/bruesewitz-v-wyeth-what-the-supreme-court-decision-means-for-vaccines

Feb 24, 2011 ... Vaccine injury is a tricky thing to prove — medically and legally. So it was inevitably controversial when the Supreme Court ruled on Tuesday against the parents of Hannah Bruesewitz, 18, who suffered seizures and permanent brain damage after receiving a diptheria-tetanus-pertussis (DTP) vaccine i...

howappealing.abovethelaw.com/SimonVsWyethReplyBriefForAppellantFinal.pdf

v. WYETH PHARMACEUTICALS, INC., et al.,. Defendants. No. 2620 EDA 2007: Appeal of plaintiff Merle Simon;. No. 2673 EDA 2007: Cross–appeal of defendant Pharmacia & Upjohn Co., LLC. REPLY BRIEF FOR APPELLANT/. RESPONSE BRIEF FOR CROSS–APPELLEE. On Appeal from the Judgment of the Court of ...

scholarship.law.georgetown.edu/cgi/viewcontent.cgi?article=2079&context=facpub

Sep 5, 2011 ... 20 Brief for Mark T. Law, et al., at 18 (emphasis in original), in PLIVA, Inc. v. Mensing, No. 09-993 (filed Mar. 2, 2011). (hereafter ''Experts Brief''), available at 2011 WL 794111, *18; see also PLIVA, 131 S. Ct. at 2584 (Sotomayor, J., dissenting). (citing same and similar data showing that ''from one-third to.

scholarship.law.georgetown.edu/cgi/viewcontent.cgi?article=2080&context=facpub

May 11, 2009 ... 2009 by The Bureau of National Affairs, Inc. (800-. 372-1033) http://www.bna.com . The U.S. Supreme Court's decision in Wyeth v. Levine sharply limited the availability of implied preemption as a defense in pharmaceutical cases. In this Analysis & Perspective, attorney Brian Wolfman discusses the decision ...

www.law360.com/cases/4d2b7c33dbf3b4079a000001

Pfizer Settles Fee Dispute In $785M FCA Deal. Pfizer Inc. and a relator who blew the whistle on false claims have agreed to resolve their dispute over how much in attorneys' fees the company should pay after its $785 million settlement. 7 other articles on this case. View all » ...

www.plainsite.org/judges/superior-court-of-california-county-of-san-francisco/katherine--feinstein

Wyeth Llc Et Al · 11/8/2012 · CGC 12 526675 · Patricia Bledsoe Et Al v. Wyeth Llc Et Al · 11/8/2012 · CGC 12 526684 · Sandra Boniol Et Al v. Wyeth Llc Et Al ...... 8/ 23/2012 · CGC 12 523628 · Niesar & Vestal Lllp v. Popover Games, Inc. Et Al · 8/ 23/2012 · CGC 12 523632 · Marc Hunte v. City And County Of San Francisco Et Al ...